Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

E-cigarettes should be promoted as a smoking cessation

Prof Linda Bauld - University of Stirling, Stirling, UK
E-cigarettes should be promoted as a smoking cessation ( Prof Linda Bauld - University of Stirling, Stirling, UK )
13 Nov 2015

Sponge test a cheaper and less invasive screening method for oesophageal cancer

Dr Rebecca Fitzgerald - University of Cambridge, Cambridge, UK
Sponge test a cheaper and less invasive screening method for oesophageal cancer ( Dr Rebecca Fitzgerald - University of Cambridge, Cambridge, UK )
13 Nov 2015

Uptake of exercise is beneficial to cancer patients

Prof Robert Thomas - Bedford and Addenbrooke's Cambridge University NHS Trusts, UK
Uptake of exercise is beneficial to cancer patients ( Prof Robert Thomas - Bedford and Addenbrooke's Cambridge University NHS Trusts, UK )
13 Nov 2015

Prognostic value of BRAFV600 mutations in stage 3 cutaneous melanoma patients

Prof Philippe Saiag - University of Versailles, Versailles, France
Prognostic value of BRAFV600 mutations in stage 3 cutaneous melanoma patients ( Prof Philippe Saiag - University of Versailles, Versailles, France )
5 Nov 2015

What are the prognostic values of 25-hydroxyvitamin D3 levels at diagnosis and follow-up?

Prof Philippe Saiag - University of Versailles, Versailles, France
What are the prognostic values of 25-hydroxyvitamin D3 levels at diagnosis and follow-up? ( Prof Philippe Saiag - University of Versailles, Versailles, France )
5 Nov 2015

Anti-PD1 or tyrosine kinase inhibitors?

Dr Mark Middleton - University of Oxford, Oxford, UK
Anti-PD1 or tyrosine kinase inhibitors? ( Dr Mark Middleton - University of Oxford, Oxford, UK )
5 Nov 2015

New drugs and new trials in melanoma

Prof Jean-Jacques Grob - Marseille University, Marseille, France
New drugs and new trials in melanoma ( Prof Jean-Jacques Grob - Marseille University, Marseille, France )
5 Nov 2015

Highlights of EADO 2015

Prof Jean-Jacques Grob - Marseille University, Marseille, France
Highlights of EADO 2015 ( Prof Jean-Jacques Grob - Marseille University, Marseille, France )
5 Nov 2015

Disruptive technologies in cancer

Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia
Disruptive technologies in cancer ( Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia )
5 Nov 2015

Latest from the CoBRIM study

Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia
Latest from the CoBRIM study ( Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia )
5 Nov 2015

Anti-PD-1 or anti-CTLA-4 in first line therapy?

Prof Claus Garbe - University of Tübingen, Tübingen, Germany
Anti-PD-1 or anti-CTLA-4 in first line therapy? ( Prof Claus Garbe - University of Tübingen, Tübingen, Germany )
5 Nov 2015

Long response and long responders in melanoma immunology

Prof Georgina Long - University of Sydney, Sydney, Australia
Long response and long responders in melanoma immunology ( Prof Georgina Long - University of Sydney, Sydney, Australia )
5 Nov 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation